background
banner

XIFAXAN 550mg Price

Active Substance: Rifaximin.

888
UAD , based on 7541 reviews.
View Drug details

Overview

Welcome to Dwaey, specifically on XIFAXAN 550mg page.
This medicine contains an important and useful components, as it consists of
Rifaximinis available in the market in concentration

Name

Rifaximin

Precaution

Rifaximin is not found to be effective in patients with diarrhea complicated by fever and/or blood in the stools. Rifaximin therapy should be discontinued if diarrhea symptoms get worse or persist for more than 24-48 hours and an alternative antibiotic therapy should be considered. Pseudomembranous colitis has been reported with nearly all antibacterial agents and may range in severity from mild to life-threatening. Therefore, it is important to consider this diagnosis in patients who present with diarrhea subsequent to the administration of antibacterial agents. Lactation: Do not use if nursing or do not nurse

Indication

Traveler's diarrhea, irritable bowel syndrome

Contra indication

Contraindicated in patients with a hypersensitivity to Rifaximin or to any of the rifamycin antimicrobial agents, or any components of this product.

Side Effect

>10% Flatulence (11%) 1-10% Headache (10%),Rectal tenesmus (7%),Abdominal pain (7%),Defecation urgency (6%),Nausea (5%),Constipation (4%),Pyrexia (3%),Vomiting (2%) Frequency Not Defined Hypersensitivity reactions (including allergic dermatitis),Pruritus,Rash

Pregnancy Category ID

3

Mode of Action

Antimicrobial action is a result of binding to the beta-subunit of bacterial DNA-dependent RNA polymerase, resulting in inhibition of transcription. Hepatic encephalopathy: Inhibits growth of enteric ammonia-producing bacteria to indirectly reduce serum ammonia level. Irritable bowel syndrome with diarrhea (off-label): Inhibits growth of enteric bacteria to reduce gas production.

Interaction

Although in vitro studies demonstrated the potential of rifaximin to interact with cytochrome P450 (CYP3A4), a clinical drug-drug interaction study demonstrated that rifaximin did not significantly affect the pharmacokinetics of midazolam. An additional clinical drug-drug interaction study showed no effect of rifaximin on the presystemic metabolism of an oral contraceptive containing ethinyl estradiol and norgestimate. Therefore, clinical interactions with drugs metabolized by human cytochrome P450 isozymes are not expected.

Pregnancy Category Note

Information not available

Adult Dose

Child Dose

Renal Dose

Administration

banner

Report Error

Please feel welcome to contact us with any price or medical error. Our team will receive any reports.